LATAM Airlines has launched a re-IPO
A group of LATAM’s main shareholders, who entered the equity as part of the Chapter 11 exit, sold 6.3% of their stake through a US book-building underwriting process. This transaction marks the reopening of the American depository receipt (ADR) program and positions LATAM Airlines as one of the most liquid stocks in Chile. The market anticipates this as the first in a series of transactions that will enable this group of main shareholders to exit their investment.
LATAM Airlines Group S.A. is the leading airline group in Latin America, with a presence in five domestic markets: Brazil, Chile, Colombia, Ecuador and Peru. It also operates internationally within Latin America and to Europe, Oceania, Africa, the USA and the Caribbean.
Oaklins’ team in Chile acted as the joint bookrunner in the underwriting of LATAM Airlines’ re-IPO, raising US$96 million from institutional investors, excluding large pension funds. The team also played a key role in after-market trading. In the week following the transaction, they accounted for 49% of the total value traded, compared to 27% in the previous weeks.


Contáctese con el equipo de la transacción
Transacciones relacionadas
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Aprenda másDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Aprenda másdoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Aprenda más